Strong IP Rights are Needed to Protect the Next Stevie Wonder, Mary J. Blige
This year’s star-studded GRAMMY Awards featured extraordinary performances by Stevie Wonder, Smokey Robinson, Missy Elliott, Mary J. Blige, Jay-Z, and more. Their groundbreaking careers and presence on the stage are reminders that the journey to superstardom is not easy. According to the Recording Industry Association of America, it can cost $2 million to break an
Strong IP Rights are Needed to Protect the Next Stevie Wonder, Mary J. Blige Read More »
America’s patent system isn’t broken — so it doesn’t need “fixing”
Dr. Rachel Goode, an executive at a German generic pharmaceutical company, recently argued that “brand-name drug companies are gaming the [U.S.] patent system” by filing duplicative patents meant to block generics manufacturers from entering the market with cheaper copy-cat treatments. But there’s scant evidence to support that claim. Brand-name drugmakers file patents at a rate
America’s patent system isn’t broken — so it doesn’t need “fixing” Read More »
New Letter from Congress Threatens Innovation Ecosystem
More than two dozen policymakers recently sent a letter to the U.S. Secretary of Health and Human Services, Xavier Becerra, calling on him to misuse a provision of the Bayh-Dole Act to lower the price of the prostate cancer drug Xtandi. The lawmakers’ request, if Becerra grants it, would chill innovation and disincentivize the launch
New Letter from Congress Threatens Innovation Ecosystem Read More »
FY2023 Omnibus Bill Includes Pro-IP Provisions, Avoids IP Landmines
WASHINGTON (December 21, 2022) — Congressional appropriators recently unveiled their $1.7 trillion omnibus funding package, which is likely to face a vote by the end of this week. Frank Cullen, executive director of the Council for Innovation Promotion, released the following statement on the package: “C4IP is pleased that pro-IP provisions were included in the
FY2023 Omnibus Bill Includes Pro-IP Provisions, Avoids IP Landmines Read More »